Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: Results from the retained organic solutes and clinical outcomes (ROSCO) investigators

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Melamed, Michal L ^a   Plantinga, Laura ^b   Shafi, Tariq ^c   Parekh, Rulan ^d   Meyer, Timothy W ^e   Hostetter, Thomas H ^f   Coresh, Josef ^c,g   Powe, Neil R ^h  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e STANFORD UNIVERSITY   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

All cause Mortality; Cardiovascular Mortality; Dialysis Outcomes; Indoxyl Sulfate; P cresol Sulfate; Uremic Solutes

Indexed keywords

4 CRESOL SULFATE; DIMETHYLAMINE; INDICAN; METHYLAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NATIONAL DEATH INDEX; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; ADVERSE EFFECTS; AGED; BLOOD; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; TRENDS;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; INDICAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84879459137     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-134     Document Type: Article

References (27)

1. United States Renal Data System, USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases 2011
2. Epidemiology of cardiovascular disease in chronic renal disease. Foley RN, Parfrey PS, Sarnak MJ, J Am Soc Nephrol 1998 9 16 S23 11443763
3. Cardiovascular and noncardiovascular mortality among patients starting dialysis. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Jama 2009 302 1782 1789 10.1001/jama.2009.1488 19861670
4. A bench to bedside view of uremic toxins. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J, J Am Soc Nephrol 2008 19 863 870 10.1681/ASN.2007121377 18287557
5. Normal and pathologic concentrations of uremic toxins. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, et al. J Am Soc Nephrol JASN 2012 23 1258 1270 10.1681/ASN.2011121175
6. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Meyer TW, Walther JL, Pagtalunan ME, Martinez AW, Torkamani A, Fong PD, et al. Kidney Int 2005 68 867 877 10.1111/j.1523-1755.2005.00469.x 16014068 (Pubitemid 43323146)
7. Methylamine clearance by haemodialysis is low. Ponda MP, Quan Z, Melamed ML, Raff A, Meyer TW, Hostetter TH, Nephrol Dial Transplant 2010 25 1608 1613 10.1093/ndt/gfp629 20019016
8. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Lin CJ, Wu CJ, Pan CF, Chen YC, Sun FJ, Chen HH, Nephrol Dial Transplant 2010 25 3693 3700 10.1093/ndt/gfq251 20466687
9. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al. Clin J Am Soc Nephrol 2009 4 1551 1558 10.2215/CJN.03980609 19696217
10. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, et al. Nephrol Dial Transplant 2010 25 1183 1191 10.1093/ndt/gfp592 19914995
11. P-cresol and cardiovascular risk in mild-to-moderate kidney disease. Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, et al. Clin J Am Soc Nephrol 2010 5 1182 1189 10.2215/CJN.07971109 20430946
12. Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P, Semin Dial 2011 24 327 337 10.1111/j.1525-139X.2011.00925.x 21682773
13. Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain kv1.6 channel subtype. Pirisino R, Ghelardini C, Pacini A, Galeotti N, Raimondi L, Br J Pharmacol 2004 142 381 389 10.1038/sj.bjp.0705740 15100162 (Pubitemid 38746173)
14. Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aodn towards kv1.1 channels. Pirisino R, Ghelardini C, Banchelli G, Galeotti N, Raimondi L, Br J Pharmacol 2001 134 880 886 10.1038/sj.bjp.0704316 11606329 (Pubitemid 33016160)
15. Methylamine-dependent release of nitric oxide and dopamine in the cns modulates food intake in fasting rats. Raimondi L, Alfarano C, Pacini A, Livi S, Ghelardini C, DeSiena G, et al. Br J Pharmacol 2007 150 1003 1010 17339841 (Pubitemid 46625090)
16. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, et al. Jama 2004 291 451 459 10.1001/jama.291.4.451 14747502 (Pubitemid 38129749)
17. Removal of p-cresol sulfate by hemodialysis. Martinez AW, Recht NS, Hostetter TH, Meyer TW, J Am Soc Nephrol 2005 16 3430 3436 10.1681/ASN. 2005030310 16120820 (Pubitemid 46187553)
18. Derivitization of methylamine and ethylamine followed by lc and fluorescence detection for measurement of urinary clearance. Quan ZPM, Melamed M, Raff A, Berman N, Scherer J, Bitzer M, Meyer T, Hostetter TH, Chromatographia 2010 71 411 10.1365/s10337-009-1464-6
19. Relationship of c-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Arterioscler Thromb Vasc Biol 1997 17 1121 1127 10.1161/01.ATV.17.6. 1121 9194763 (Pubitemid 27260332)
20. Comparison of causes of death using hemo study and hcfa end-stage renal disease death notification classification systems. The National Institutes of Health-Funded Hemodialysis. Health Care Financing Administration. Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, et al. Am J Kidney Dis 2002 39 146 153 10.1053/ajkd.2002.29905 11774113 (Pubitemid 34062507)
21. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Miskulin DC, Martin AA, Brown R, Fink NE, Coresh J, Powe NR, et al. Nephrol Dial Transplant 2004 19 413 420 10.1093/ndt/gfg571 14736967 (Pubitemid 38195992)
22. Uremia. Meyer TW, Hostetter TH, N Engl J Med 2007 357 1316 1325 10.1056/NEJMra071313 17898101 (Pubitemid 47481454)
23. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW, Am J Kidney Dis 2009 53 1042 1049 10.1053/j.ajkd.2009.01.265 19394728
24. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y, Kidney Int 2006 69 1081 1087 10.1038/sj.ki.5000115 16421516 (Pubitemid 43372184)
25. Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease. Terrier-Lenglet A, Nollet A, Liabeuf S, Barreto DV, Brazier M, Lemke HD, et al. Nephrologie therapeutique 2011 7 219 224 21316322
26. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al. Kidney Int 2011 80 1080 1091 10.1038/ki.2011.213 21775973
27. In-center hemodialysis six times per week versus three times per week. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, et al. N Engl J Med 2010 363 2287 2300 21091062 Kidney Diseases